UVB Radiation May Protect Against Severe COVID-19
Recent study results show that vitamin D may offer protection against critical disease and death.
Vitamin D may protect against severe COVID-19 and death, the results of a study published in Scientific Reports show.
“Our study adds further evidence that vitamin D might protect against severe COVID-19 infection. Conducting a properly designed COVID-19 randomized controlled trial of vitamin D supplementation is critical,” Lina Zgaga, associate professor in epidemiology at the school of medicine at Trinity College, said in a statement.
“Until then, given that vitamin D supplements are safe and cheap, it is definitely advisable to take supplements and protect against vitamin D deficiency, particularly with winter on the horizon,” she said.
The study results showed that an individual’s place of residence with ambient ultraviolet B (UVB) radiation offered protection against severe disease and death. Almost a half a million individuals in the United Kingdom took part in the UVB study before investigators individually assessed the COVID-19 infection for each participant.
UVB radiation promotes vitamin D production in the skin, and investigators previously linked vitamin D deficiency with an individual being more susceptible to bacterial and respiratory infections.
Investigators found that are were many factors to consider, but they were able to calculate a “genetically-predicted” vitamin D level by taking in the UVB radiation of sunshine, which investigators felt had been ignored.
“Given the lack of highly effective therapies against COVID-19, we think it is important to remain open-minded to emerging results from rigorously conducted studies of vitamin D,” Evropi Theodoratou, professor of cancer epidemiology and global health at the University of Edinburgh, said in the statement.
A potential causal effect was noted, and a larger future study should be conducted, according to the investigators.
Reference
Further evidence that vitamin D might protect against severe COVID-19 disease and death. EurekAlert. News release. September 15, 2021. Accessed September 16, 2021.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025